Introduction {#s1}
============

Most neurons in the brain are generated at specific developmental time points, and once a neuron becomes postmitotic regeneration following injury is limited, except for in two forebrain regions that maintain neurogenesis ([@bib9]). In the context of injury, adult forebrain neurons undergo limited recovery that involves either reactive gliosis ([@bib6]; [@bib28]; [@bib32]) or migration of neural stem cells from the neurogenic niches ([@bib3]; [@bib21]; [@bib22]; [@bib25]). The cerebellum (CB) of the hindbrain has a complex folded structure that houses the majority of neurons in the brain and is essential for balance and motor coordination, as well as higher order reasoning via circuits it forms throughout the forebrain ([@bib11]; [@bib34]; [@bib36]; [@bib37]; [@bib38]). For two weeks after birth, the postnatal mouse CB consists of both neurons generated in the embryo, and two neurogenic progenitor pools that produce late born neurons and glia. Interestingly, the proliferating granule cell progenitors can be replenished following injury by adaptive reprograming of the second Nestin-expressing progenitors ([@bib42]). However, once a neurogenic process has ended, the degree to which post mitotic neurons can undergo regeneration is poorly understood.

Purkinje cells (PC) are born by embryonic day (E) 13.5 in the mouse and during weeks 10--11 in humans ([@bib27]; [@bib40]). After exiting the cell cycle in the ventricular zone, PCs express FOXP2 as they migrate to form a PC layer (PCL) under the cerebellar surface by E17.5, and turn on Calbindin1 (CALB1) in the late embryo and stop expressing FOXP2 by two weeks after birth. PCs play a central role in postnatal CB development by being the main source of sonic hedgehog (SHH), which is required for proliferation of granule cell progenitors and Nestin-expressing progenitors that produce interneurons and astrocytes ([@bib10]; [@bib13]; [@bib19]). PCs also are key for CB function by integrating the inputs that converge on the cerebellar cortex ([@bib31]). Hence, PC loss is linked to cerebellar motor behavior syndromes and has also been implicated in autism ([@bib11]; [@bib37]; [@bib39]). In this study we determined the regenerative potential of PCs in neonatal mice.

Results and discussion {#s2}
======================

To ablate and track PCs, the diphtheria toxin receptor (DTR) and a lineage tracer, TdTomato (TdT), were expressed in a subpopulation of PCs using a transgenic approach (*Pcp2^Cre/+^; R26^LSL-DTR/LSL-TdT^* or *PC-DTR* mice; LSL = lox stop-lox). We found that only 52.16 ± 21.84% of PCs (n = 5 mice), identified by expression of CALB1, expressed TdT and DTR at postnatal day (P) 1, and surprisingly the percentage and large variation remained similar at P5 and P30 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Strikingly, when DT was injected at P1 into *PC-DTR* pups (P1-*PC-DTR)*, nearly all TdT+ PCs formed an ectopic layer below the PC layer (PCL) by 1 day post injection (dpi) ([Figure 1A--M](#fig1){ref-type="fig"}). The ectopic layer was absent by P8 ([Figure 1K](#fig1){ref-type="fig"}), and TdT+ cells in the ectopic layer were TUNEL positive starting at P3 with a peak at P5. These results show that almost all DTR-expressing TdT+ cells become misplaced, die and are cleared within 5--7 dpi of DT ([Figure 1N,O](#fig1){ref-type="fig"}).

![Ablation of PCs at P1 stimulates their replenishment and development of normal CB size and morphology.\
(**A**) The experimental plan. (**B--M**) IF analysis at the indicated ages for TdT and CALB1 in sagittal cerebellar sections of lobule IV-V in No DT (B-G) and P1-*PC-DTR* mice (H-M). (**N--O**) Analysis of apoptosis at P5 using TUNEL. (**P**) Quantification of CALB1+ cells per midline section in PCL (blue or red) and ectopic layer (grey) (PCL cells: Two-way ANOVA F~(5,54)~=4.034, p=0.0035, and total number of PCs: Two-way ANOVA F~(5,27)~=4.732, p=0.003, n ≥ 3 animals/condition). (**Q**) Quantification of TdT+ cells per section (PCL cells: Two-way ANOVA F~(5,48)~=6.957, p=0.0001). Significant *post hoc* comparisons are shown. (**R--S**) H and E stained midline sagittal sections of cerebella at P30 of No DT (**R**) and P1-*PC-DTR* (**S**) mice. (**T**) Quantification of midline sagittal areas of cerebella shows no differences upon DT injection (p=0.89, n ≥ 3 for each age). Scale bars: (**B--O**) 200 μm, (**R--S**) 500 μm. (EGL: external granule layer, PCL: Purkinje cell layer).\
10.7554/eLife.39879.007Figure 1---source data 1.Summary of the antibodies used in the study.\
10.7554/eLife.39879.008Figure 1---source data 2.Summary of the statistics performed.](elife-39879-fig1){#fig1}

Unexpectedly, although the number of CALB1+ PCs in the PCL of P1-*PC-DTR* mice was significantly reduced at P2 compared to non-injected controls (No DT), it was not significantly reduced at P3 and later stages ([Figure 1P](#fig1){ref-type="fig"}). Furthermore, the total number of PCs (ectopic layer + PCL) was significantly greater in DT-injected cerebella than in No DT controls at P2 and P3, and the total number of PCs was down to normal levels at P5, overlapping with the time of clearance of the ectopic layer ([Figure 1P](#fig1){ref-type="fig"}). Although the number of TdT+ cells in the PCL increased between P8 and P30 in P1-*PC-DTR* brains, it remained significantly lower than in No DT controls at P30 ([Figure 1Q](#fig1){ref-type="fig"}). Given that there is no significant increase in the recombination induced by *Pcp2^Cre^* after birth in the control postnatal CB ([Figure 1Q](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1F](#fig1s1){ref-type="fig"}), the percentage of TdT+ cells in *P1-PC-DTR* brains at P30 (\~25--30%) matched the predicted percentage if 50% of the PCs were killed by DT and then \~50% of the regenerated PCs underwent recombination. Interestingly, and consistent with the rapid recovery of PC numbers in the PCL, no significant decrease in the sectional area of the CB was observed between P1.5 and P30 ([Figure 1R--T](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Furthermore, the thickness of the outer (proliferating) and inner (differentiating) external granule cell layers remained normal ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). In summary, we uncovered that the CB can rapidly recover (within 24--48 hr) from the loss of \~50% of PCs at P1, by producing new PCs and resuming normal growth.

In order to document the rapid production of new PCs after ablation, we tested whether PCs that had recently undergone cell division could be detected at P3. P1-*PC-DTR* mice were divided into four groups; each group receiving three injections of BrdU (2 hr apart) during 4--26 hr after DT-injection ([Figure 2A](#fig2){ref-type="fig"}). As predicted, BrdU+ PCs (FoxP2+ and CALB1+) were observed in the PCL of all groups ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), with the greatest incorporation being between 10--20 hr after DT ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Importantly, in No DT mice no incorporation of BrdU was observed in PCs ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Curiously, FOXP2 and BrdU showed non-overlapping subnuclear localization in the nuclei of PCs. In addition, when we analyzed brains of P1-*PC-DTR* mice at P30 that had received BrdU 10--14 hr after DT injection, we observed BrdU+ mature PCs with similar cell bodies and dendritic trees to their neighbors, showing that the newly generated PCs differentiate and survive to adulthood ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Furthermore, a lack of BrdU incorporation in the ectopic layer at P3 shows that the labeling of PCs is not due to DNA damage induced by DT-mediated cell death ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}).

![Progenitors proliferate within 24 hr of DT-injection at P1 in *PC-DTR* mice and produce new PCs.\
(**A**) The experimental plan. (**B**) Quantification of the number of BrdU+ PCs (CALB1+) at P3 in P1-*PC-DTR* mice (Two-way ANOVA F~(3,16)~=6.163, p=0.006, n = 3 animals/condition). Significant *post hoc* comparisons are designated in the figure. (**C**) Representative images of BrdU injection performed at 10--14 hr post DT injection in P3 P1-*PC-DTR* CB. (n = 3 animals/condition). Orthogonal view from z-stack obtained by confocal microscopy demonstrates colocolization of BrdU and FOXP2 after PC depletion. (**D**) Experimental plan for retroviral labeling. P1-*PC-DTR* pups were injected with GFP expressing retrovirus to label proliferating cells and the brains were analyzed 3 weeks later. (**E--I**) IF analysis shows examples in two mice of each genotype of rare retrovirus labeled PCs (arrows) following regeneration (**G, H**) only in P1*-PC-DTR* mice. GFP+ GCs (asterisk) and Bergmann glia cells (arrow head) were observed in No DT (**E, F**) and *P1-PC-DTR* (**I**) mice (n = 6 mice/condition). G' and I' shows GFP-expressing PC and a Bergmann glia cell. Scale bars: 50 μm.](elife-39879-fig2){#fig2}

In order to further confirm that BrdU incorporation is not due to DNA damage following DT injection, we treated P1 pups either with 4Gy γ-irradiation or DT at P1 followed by three BrdU injections (2 hr apart) at 30 min or 10 hr after treatment, respectively. The brains were then analyzed 24 hr after the last BrdU injection. In the irradiated pups we observed extensive γ-H2AX foci, including in PCs, but BrdU incorporation was not detected in any PCs. In contrast, P1-*PC-DTR* mice injected with DT showed BrdU incorporation in PCs without any γ-H2AX foci ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Thus, DNA damage does not account for the BrdU incorporation into PCs following ablation of \~50% of PCs at P1.

As a second means to specifically label dividing cells that give rise to new PCs, we intracranially injected GFP-expressing retrovirus into P1-*PC-DTR* pups and littermate controls 12 hr after DT injection, since retroviruses can only incorporate into the DNA of dividing cells and are widely used for clonal analysis of neural stem cells and progeny ([Figure 2D](#fig2){ref-type="fig"})([@bib8]; [@bib44]). When the mice were analyzed at P21, we indeed observed rare GFP-labeled CALB1+ PCs in P1-*PC-DTR* animals near the site of injection, and not in No DT controls. As expected, GFP+ granule cells and Bergmann glia were observed in both the No DT and P1-*PC-DTR* mice ([Figure 2E--I](#fig2){ref-type="fig"}). These three sets of experiments thus reveal that a progenitor capable of proliferating produces the new PCs after ablation at P1.

Based on the rapid replenishment of PCs after ablation at P1, we hypothesized that a local progenitor in the PCL must be responsible for the response. The Nestin-expressing progenitors (NEPs) in the PCL were a candidate, as they display plasticity upon ablation of granule cell precursors in newborn mice ([@bib42]). Furthermore a putative rare Nestin+ cell in the adult CB was recently described as able to produce new neurons in response to exercise ([@bib1]). However, when we tested the contribution of NEPs to PC regeneration using a *Nes-CFP* reporter allele that transiently maintains CFP protein after differentiation, no CFP+ cells were found to co-express FOXP2 or CALB1 at 12 hr and 2 days post DT injection in P1-*PC-DTR* mice and in No DT controls ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). Furthermore, inducible fate mapping of NEPs using *Nestin-FlpoER/+; R26^FSF-TdT/+^* (FSF = frt stop-frt) mice showed no TdT+ PCs at P30 in P1-*PC-DTR* and No DT control mice given tamoxifen at P0 ([Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}). These results suggest that a progenitor other than NEPs mediates regeneration following PC depletion.

We next examined whether a progenitor exists after birth that expresses early (FOXP2) but not late (CALB1) PC markers. Indeed, at P1 we identified CALB1 negative/low and FOXP2-expressing cells that could be immature PCs (named iPC for immature Purkinje cells; [Figure 3A--B](#fig3){ref-type="fig"}, [Figure 3---video 1](#fig3video1){ref-type="video"}). Possibly accounting for the regeneration of PCs, iPCs were not labeled by *Pcp2^Cre^* as they were TdT and DTR negative in No DT controls, thus they escape DT-mediated cell death ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Temporal analyses revealed a decrease in the number of iPCs from P1 (74.33 ± 5.69/midline sagittal section) to P5 (28.66 ± 7.51/midline sagittal section, [Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), indicating the progenitors are a transient population. Interestingly, the few iPCs present at P5 were specifically enriched in the central and nodular zones of the CB, which are developmentally delayed at P5 ([@bib18]; [@bib35])([Figure 3A](#fig3){ref-type="fig"}).

![The number of iPCs diminishes with age and increases after ablation of PCs.\
(**A**) Schematic representation of the distribution of iPCs (red) in sagittal midline sections of P1-5 cerebella (yellow, FoxP2+ and CALB1+ PCs) (**B**) IF analysis of iPCs (FoxP2+ and CALB1-/low, arrow) at P1.5 in No DT mice. (**C**) Quantification of the numbers of iPCs and PCs at P1, P5 and P30 (CALB1+: One-way ANOVA F~(2.6)~ = 6.883, p=0.028, iPCs: Student's t-test: p=0.0009, all cells: One-way ANOVA F~(2.6)~ = 1.813, p=0.24, n = 3 animals/condition). Significant *post hoc* comparisons are shown. (**D**) Quantification of the numbers of iPCs at P1.5 (Two-tailed t-test, p=0.005, n = 3) and P5 (Two-tailed t-test, p=0.04, n = 3) in No DT and P1-*PC-DTR* mice. (**E--N**) Orthogonal projections of z-stack shows a EdU+ PC (CALB1+, FOXP2+) (**E--I**) or iPC (CALB1-/low, FOXP2+) (**J--N**) at 15 hr post injection (hpi) in P1-*PC-DTR* mice (n = 3). (**O--X**) Orthogonal projections of z-stack shows EdU+ and FOXP2+ cells that either express the cell cycle markers KI67 (**O--S**) or pH3 (**T--X**) at 15 hr post injection (hpi) in P1-*PC-DTR* mice (n = 3). Scale bars: (**B**) 100 μm, (**E, J, O, T**) 50 μm.](elife-39879-fig3){#fig3}

In order to investigate the normal fate of iPCs, we tested whether there is an increase in the number of CALB1+ PCs from P1 to P30. In order to minimize variation across animals, we used the C57BL/6 inbred strain of mice and analyzed the entire half-vermis of each brain (every second section). As expected, a significant reduction in the number of iPCs was observed between P1 and P5, but in addition we detected a significant increase in the number of CALB1+ cells at P30 compared to P1 ([Figure 3C](#fig3){ref-type="fig"}). At P5 there was a trend towards an increase in the number of CALB1+ cells. There was also a trend towards a reduction in the total number of iPCs plus CALB1+ cells at P5 and P30 compared to P1 ([Figure 3C](#fig3){ref-type="fig"}), suggesting that some PCs may also undergo apoptosis during early postnatal development. These results provide evidence that iPCs are cells destined to become PCs, but normally undergo a delay in differentiation until the first week after birth.

We then asked whether the number of iPCs increases after DT treatment of P1-*PC-DTR* mice. Quantification of iPC numbers showed a significant increase 12 hr after DT injection in P1-*PC-DTR* mice (1.90 ± 0.05 fold, [Figure 3D](#fig3){ref-type="fig"}), correlating with the time window of highest BrdU incorporation after injury ([Figure 2B](#fig2){ref-type="fig"}). Interestingly, at P5 the number of iPCs was significantly lower in P1-*PC-DTR* animals than in No DT mice ([Figure 3D](#fig3){ref-type="fig"}), possibly reflecting an exhaustion of the progenitor population by production of new PCs. To further show that iPCs expand in number after their neighbors are killed, we used constitutive FLP-based fate mapping in *FoxP2^Flpo/+^; R26^FSF-TdT/+^* mice to transiently mark and follow PCs and iPCs. We found that all CALB1+ PCs and iPCs expressed TdT at P1 ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}), and as predicted, an increase in transiently fate mapped TdT+ iPCs was seen in P1-*PC-DTR* mice 12 hr after DT injection at P1 compared to No DT controls (1.86 ± 0.46--fold, n = 3, [Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). Thus, iPCs expand in number after damage to neighboring PCs.

To confirm that iPCs undergo proliferation upon PC depletion, we injected BrdU or EdU 10--14 hr after DT and collected cerebella 1 hr (\~P1.5) later. Other than glial progenitors and microglia seen in No DT controls ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}), all additional BrdU+ (or EdU+) cells in the PCL of P1-*PC-DTR* mice expressed FOXP2, and of these cells 45.5 ± 1.1% expressed CALB1 ([Figure 3E--N](#fig3){ref-type="fig"}, [Figure 3---figure supplements 5](#fig3s5){ref-type="fig"},[6](#fig3s6){ref-type="fig"}). Furthermore, the total number of FOXP2+ cells in the PCL that were acutely labeled with BrdU, was similar to the number of BrdU+ cells that became PCs (CALB1+) at P3 (38.7 ± 9.1/section vs 40.3 ± 19.0/section, n = 3, [Figure 3---figure supplement 5](#fig3s5){ref-type="fig"}). In addition, FOXP2+ cells that were Ki67+ ([Figure 3O--S](#fig3){ref-type="fig"}, [Figure 3---figure supplement 6C](#fig3s6){ref-type="fig"}) or pH3+ ([Figure 3T--X](#fig3){ref-type="fig"}, [Figure 3---figure supplement 6D](#fig3s6){ref-type="fig"}) and EdU+ were detected at P1.5 in the PCL of P1-*PC-DTR* pups, confirming the presence of proliferative iPCs following PC ablation. In order to further study the cell-cycle state of iPCs in uninjured cerebella, we analyzed the expression levels of the cell cycle inhibitor P27^Kip1^ ([@bib41]) and KI67 in iPCs compared to CALB1 high FOXP2+ PCs at P1. Fluorescent intensity analyses revealed that PCs have higher P27 and lower KI67 expression levels compared to iPCs ([Figure 3---figure supplement 7](#fig3s7){ref-type="fig"}). Collectively, our data argues that the recovery of PCs in P1-*PC-DTR* mice is mediated by a previously unrecognized and age-dependent progenitor population (iPCs) that normally transitions to a CALB1+ PC, but in response to loss of PCs proliferates and differentiates to replace the lost cells.

Given that the population of iPCs is greatly reduced by P5 ([Figure 3C](#fig3){ref-type="fig"}), PCs should not be efficiently replaced if ablated at P5, when similar to at P1 *Pcp2^Cre^* induces recombination (expression of DTR) in 40.5 ± 21.5% of CALB1+ PCs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). As predicted, when DT was injected at P5 (P5-*PC-DTR* mice) ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), the number of PCs was significantly reduced at P12 compared to No DT controls ([Figure 4---figure supplement 1B--I,R](#fig4s1){ref-type="fig"}). TdT+ PCs were TUNEL+ by P8 ([Figure 4---figure supplement 1J--K](#fig4s1){ref-type="fig"}) and the majority of TdT+ cells were cleared from the PCL by P12 ([Figure 4---figure supplement 1G,P and S](#fig4s1){ref-type="fig"}). Furthermore, in P5-*PC-DTR* mice at P8 and P12 the dendrites and cell bodies of the PCs were poorly organized compared to in controls ([Figure 4---figure supplement 1B--G and L--P](#fig4s1){ref-type="fig"}) and at P30 the cell bodies of some PCs were misplaced into the molecular layer ([Figure 4---figure supplement 1N--R](#fig4s1){ref-type="fig"}). Importantly, the reduction in PC numbers observed at P12 was maintained at P30 ([Figure 4---figure supplement 1R](#fig4s1){ref-type="fig"}), such that the number of PCs was reduced by 32.4 ± 6.5%. In summary, there is little replenishment of PCs when they are ablated at P5 ([Figure 4A](#fig4){ref-type="fig"}).

![Despite the recovery of CB size, PCs are poorly replenished and motor behavior deficits develop when PCs are killed at P5 but not at P1.\
(**A**) Number of CALB1+ cells at P30 (One-way ANOVA, F~(2,16)~=9.464, p=0.002, n ≥ 6). (**B**) Number of BrdU+ PCs 2 days post DT-injection in P1- or P5-*PC-DTR* mice (Two-tailed t-test, p=0.04). (**C**). Quantification of CB area in midline sagittal sections demonstrates that CB size is smaller at P12 in P5-*PC-DTR* mice but not later (Two-way ANOVA, F~(1,22)~=7.045, p=0.01, n ≥ 3). (**D--E**) PC soma size (D, One-way ANOVA, F~(2.11)~ = 20.56, p=0.0002, n ≥ 4) and primary and secondary dendrite lengths (E, One-way ANOVA, F~(2,11)~=14.54, p=0.0008, n ≥ 4) at P30 were increased in P5*-PC-DTR* animals compared to No DT and P1-*PC-DTR* animals. (**F--G**) Latency to fall from rotarod at each trial (F, Two-way ANOVA, F~(2,34)~=8.37, p=0.001, n ≥ 9) and cumulative analysis (G, One-way ANOVA, F~(2,34)~=11.12, p=0.0002, n ≥ 9, No DT vs. DT\@P1: p=0.83) for P30 P5*-PC-DTR* animals compared to No DT and P1-*PC-DTR* animals. (**H**) Analysis of grip strength showed no change in P1 (n = 9, vs No DT: p=0.89) and P5 (n = 11, vs. No DT: p=0.84, vs. DT\@P1: p=0.64) DT-injected mice compared to controls (No DT, n = 17). (**I--J**) Representative images (**I**) and quantification (**J**) of footprint analysis performed on P1- (vs. No DT: stride: p=0.10 and sway: p=0.90) and P5-*PC-DTR* mice and controls (Two-way ANOVA, F~(2,133)~=73.45, p=0.0001, n ≥ 9). Significant *post hoc* comparisons are shown.](elife-39879-fig4){#fig4}

We next tested whether the rare iPCs at P5 ([Figure 3A](#fig3){ref-type="fig"}) can still proliferate upon PC depletion. In contrast to P1-*PC-DTR* mice, very few iPCs/PCs were BrdU+ in P5-*PC-DT*R cerebella injected with BrdU at 10--14 hr post DT-injection at both 1 hr (5.55 ± 0.51/ midline sagittal section, n = 3) and 1.5 days (6.22 ± 1.07/ midline sagittal section, n = 3, [Figure 4B](#fig4){ref-type="fig"}) post BrdU-injection. The few BrdU+ iPCs/PCs present were concentrated in the central and the nodular zones that are enriched for iPCs at P5 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Interestingly, compared to P1-*PC-DT*R mice in which 52.29 ± 0.09% (n = 3) of iPCs incorporated BrdU, only 20.55 ± 0.07% (n = 3) incorporated BrdU in P5-*PC-DTR* animals. Overall, these results demonstrate that replenishment of PCs is not efficient at P5 because with age, iPCs both diminish in number and in their ability to proliferate in response to PC depletion.

We next examined whether the depletion of PCs in P5-*PC-DTR* mice had an effect on CB development. Indeed, the area of CB sections was significantly reduced at P12 but not P8 ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 3](#fig4s3){ref-type="fig"} although the thickness of the external granule cell layer was significantly reduced in P5-*PC-DTR* mice at P8. By P12 the thickness of the external granule cell layer was similar in PC-ablated mice and controls ([Figure 4---figure supplement 4A--E](#fig4s4){ref-type="fig"}). Surprisingly, despite the lack of recovery of PC numbers we found that the area of the CB was normal at P16 and P30 ([Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 3A--I](#fig4s3){ref-type="fig"}). As a consequence, there was a reduction in PC density compared to No DT or to P1-*PC-DTR* mice ([Figure 4---figure supplement 3J](#fig4s3){ref-type="fig"}, [Figure 4---figure supplement 2N,Q](#fig4s2){ref-type="fig"}). The density of granule cells also was lower compared to No DT and P1-*PC-DTR* P30 mice ([Figure 4---figure supplement 4F](#fig4s4){ref-type="fig"}). Interestingly, PCs in P5-*PC-DTR* mice had a larger soma ([Figure 4D](#fig4){ref-type="fig"}) and longer primary and secondary dendrites ([Figure 4E](#fig4){ref-type="fig"}) compared to No DT or P1-*PC-DTR* mice, a cellular phenotype observed in some mouse mutants with PC loss ([@bib7]). Furthermore, compared to controls, the percentage of PCs present at P30 in P5-*PC-DTR* animals compared to No DT controls (\~66%) did not match the percentage of granule cells that were produced (\~81% of No DT controls). Thus, the ratio of PCs to granule cells is disrupted in P5-*PC-DTR* animals because granule cells are over-produced. These results reveal that independent of iPCs being stimulated to produce new PCs following their ablation, there are mechanisms of cell and organ size regulation that ensure recovery of CB size.

Finally, given that the circuitry (proportions of neurons) is disrupted in P5-*PC-DTR* mice and not P1-*PC-DTR* mice but CB size is normal in both, we tested whether either mutant has normal motor function at P30. Interestingly, P1-*PC-DTR* animals had no significant changes in their motor function compared to controls ([Figure 4F--J](#fig4){ref-type="fig"}), whereas P5-*PC-DTR* mice showed a significant reduction in their latency to fall from the rotarod and had a shorter stride compared to both No DT and P1-*PC-DTR* mice ([Figure 4F--G and I--J](#fig4){ref-type="fig"}) but no change in grip strength ([Figure 4H](#fig4){ref-type="fig"}). These results demonstrate that P5-*PC-DTR* mice, but not P1-*PC-DTR* mice, have motor behavior deficits. Thus, rapid production of new PCs by iPCs enables establishment of functional circuits following depletion of PCs at P1. Furthermore, achieving correct cell numbers and/or proportions appears to be more important than maintaining CB size for functional recovery after injury in P5-*PC-DTR* mice.

In summary, we discovered a new regenerative process in the developing CB involving a previously unidentified and normally dormant and immature PC progenitor (iPC) that is able to expand and produce additional PCs, likely to buffer against early postnatal loss of these postmitotic neurons due to injury. Proliferation of iPCs is stimulated by ablation of PCs at P1 and importantly the response is rapid (10--48 hr), ensuring other components of the developing CB that are dependent on PCs for their proliferation or differentiation are not compromised. However, iPCs decrease in number and their capacity to proliferate during the first postnatal week, and consequently PCs are poorly replenished when ablated at P5. The cerebella of P5-*PC-DTR* mice nevertheless try to adapt by attaining near normal dimensions through a mechanism that includes increasing cell size ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). The CB therefore has multiple mechanisms for regulating organ size following perinatal injury that depend on the precise stage of development. Furthermore, the motor deficits seen in P5-*PC-DTR* mice highlight the importance of maintaining the correct number of PCs and relative neuron proportions during development, not just organ size.

One possible reason for why iPCs differentiate into PCs after P1 and lose their ability to proliferate is that a critical component of the microenvironment that supports iPCs is diminished soon after birth, perhaps as a consequence of a developmental clock that the cells in the microenvironment follow. A second possibility is that the differentiation of iPCs is dictated by the timing of the establishment of the cerebellar circuitry. We speculate that efficient regeneration is possible at P1 because PCs still have an immature morphology and integration into the cerebellar circuitry, whereas at later stages the parallel fibers (axons of granule cells) synapse with PCs and climbing fibers (axons of the inferior olive neurons) refine their synapses and both cells promote PC maturation ([@bib14]; [@bib16]). Thus, maturation and integration of a newly generated PC into the cerebellar circuitry might not be efficient or possible after P5. By extrapolation, the replenishment process has evolved such that developmental plasticity is tightly correlated with age-dependent maturation of the neural circuit.

An additional cellular process to consider for the age-dependency of regeneration is the ability of neurons to enter back into the cell-cycle. Most differentiated neurons, including PCs, when forced to proliferate undergo apoptosis ([@bib12]). However, previous reports have shown that following experimental manipulation or neurodegeneration, ectopic proliferation of adult retinal and pyramidal neurons can occur ([@bib2]; [@bib29]; [@bib33]; [@bib43]). Our data indicate that iPCs, which lack the mature PC marker CALB1 and express the immature marker FOXP2, show low expression of P27 and weak but higher expression of KI67 compared to CALB1+ PCs, suggesting that their cell-cycle exit may be incomplete. CALB1+ PCs, likely ones that recently began making CALB1 protein, also appear to be able to re-enter the cell-cyle. However, the increase in the number of iPCs \~12 hr after DT administration suggests that the main regenerative response is achieved by the proliferation of iPCs.

The regenerative processes previously described in neuronal tissues involve adaptive reprograming of cells that are either actively proliferating or retain proliferative capacity and also have cell fate plasticity ([@bib3]; [@bib6]; [@bib17]; [@bib20]; [@bib21]; [@bib22]; [@bib25]; [@bib28]; [@bib30]; [@bib32]; [@bib42]). Here we identified a distinct regenerative process that involves a local and normally dormant or immature progenitor. Unlike NEPs of the CB or astrocytes and neural stem cells in the forebrain that produce neurons upon injury, iPCs do not require reprograming and cell fate plasticity as our data indicates that they normally produce additional CALB1+ PCs after birth. Thus, iPCs maintain their lineage decision, but proliferate and then mature upon injury. An important question raised by our study is whether regeneration of postmitotic neurons by age-dependent progenitors is unique to the CB where protracted development might provide a conducive milieu, or whether all brain regions retain similar progenitors for a particular time window after each neuron subtype is generated. Furthermore, understanding the mechanisms of PC regeneration in newborn mice could provide insights into how regeneration in the adult brain can be enabled.

Materials and methods {#s3}
=====================

Animals {#s3-1}
-------

All the experiments were performed according to protocols approved by the Memorial Sloan Kettering Cancer Center's Institutional Animal Care and Use Committee (IACUC). Animals were given access to food and water *ad libitum* and were housed on a 12 hr light/dark cycle.

The following mouse lines were used for these experiments: *Pcp2^Cre^* ([@bib45]), *Nestin-CFP ([@bib26];* [@bib42]), *Nestin-FlpoER* ([@bib42]), *FoxP2^Flpo^* ([@bib4]), *Rosa26^LSL-DTR^* (Stock no: 007900, The Jackson Laboratories)([@bib5]), *Rosa26^LSL-TdT^* (*ai14*, Stock no: 007909, The Jackson Laboratories)([@bib24]), *Rosa26^FRT-STOP-FRT-TdT^* derived from Ai65 (Stock no: 021875, The Jackson Laboratories)([@bib23]), C57BL/6J (Stock no: 00664, The Jackson Laboratories). Both sexes were used for analyses and no randomization was used. Exclusion criteria for experimental data points were sickness or death of animals during the testing period. No randomization was used and masking was used only for the behavior studies where the experimenter was blind to the genotypes.

Diphtheria toxin (30 μg/g of mouse; List Biological Laboratories, Inc.) was injected subcutaneously either at postnatal day (P) one or P5 and the brains were collected at various ages ([Figure 1a](#fig1){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Mice not given DT (No DT mice) were *Pcp2^Cre/+^; R26^DTR/LSL-TdT^* littermates and injected with the same volume of vehicle (PBS). BrdU or EdU (50 μg/g of mouse; Sigma) was injected subcutaneously.

Tissue preparation and histological analysis {#s3-2}
--------------------------------------------

For P5 and younger animals, brains were dissected and fixed in 4% paraformaldehyde (PFA) for 24--48 hr (h) at 4°C. Animals older than P5 were anesthetized using intraperitoneal injection of a Ketamine (100 mg/kg) and Xylaxine (10 mg/kg) cocktail. Once full anesthesia was achieved, animals were systemically perfused with ice-cold PBS, followed by 4% PFA. Brains were dissected and post-fixed in 4% PFA for 24--48 hr. Fixed brains were allowed to sink in 30% Sucrose in PBS solution and then embedded in OCT (Tissue-Tek) for cryosectioning. 14 μm-thick cryosections were obtained using a Leica cryostat (CM3050S) and mounted on glass slides. Frozen sections were stored at −20°C for future analysis. In order to generate the 3D renderings in [Figure 3---video 1](#fig3video1){ref-type="video"} 60 μm-thick cryosections were obtained and staining was performed on free floating sections. Haematoxylene and Eosin (H and E) staining was performed to assess cerebellar cytoarchitecture and measure area (size).

For immunofluorescent (IF) analysis, slides were allowed to warm to room temperature (RT). After washing once with PBS, slides were blocked using 5% Bovine Serum Albumin (BSA, Sigma) in PBS-T (PBS with 0.1% Triton-X) for 1 hr at RT. Slides were then incubated overnight at 4°C with primary antibodies diluted in blocking buffer. [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. summarizes the primary antibodies used in this study. Upon primary antibody incubation, slides were washed with PBS-T (3 × 5 min), incubated with specific AlexaFluor-conjugated secondary antibodies (1:500 in blocking buffer, Invitrogen) for 1 hr at RT and then washed again with PBS-T (3 × 5 min). Counterstaining was performed using Hoechst 33258 (Invitrogen) and the slides were mounted with Fluoro-Gel mounting media (Electron Microscopy Sciences). EdU was detected using a commercial kit following the manufacturer's recommendations (Invitrogen Cat no: C10340).

Retrovirus injection {#s3-3}
--------------------

The super folding (sf)-GFP-expressing VSVG-pseudotyped gamma-retrovirus (Moloney murine leukemia virus) was made in HEK293T (ATCC \#CRL-11268) cells using the pCMV-vsvg and pCMV-gp packaging plasmids and pUX-sf-GFP retrovirus vector plasmid (cloned by inserting sf-GFP into the BglII and NotI sites of the pUX plasmid ([@bib15]) as previously described ([@bib44]; [@bib46]). 10--12 hr after DT injection, P1 P1-*PC-DTR* pups were anesthetized by hypothermia. 3 μL of (sf)-GFP-expressing retrovirus particles (\>10^9^ Tu/mL) were injected intracranially into P1 vermal cerebella using a stereotactic apparatus. On average 12--15 sections were analyzed that were \~50 μm apart around the injection site. 7--9 retroviral-labeled PCs per mouse were detected only in the P1-*PC-DTR* brains (n = 6/ condition)

Irradiation {#s3-4}
-----------

An X-RAD 225Cx (Precision X-ray) microirradiator in the Small Animal Imaging Core Facility at Memorial Sloan Kettering Cancer Center was used to provide a single dose of 4 Gy irradiation, as previously described ([@bib42]), to P1 pups anesthetized by hypothermia. The CB was targeted using a collimator with 5 mm diameter.

Image acquisition and analysis {#s3-5}
------------------------------

Images were collected either with a DM6000 Leica microscope or Zeiss LSM 880 confocal microscope and processed using ImageJ Software (NIH).

For each quantification, three midline parasagittal sections/brain were analyzed and data was averaged. Cells were counted using the Cell Counter plugin for ImageJ (NIH). Analyses of the numbers of PCs and iPCs were performed by counting all of the PCs on a midline parasagittal section. CB area was calculated by defining a region of interest by outlining the perimeter of the outer edges of the CB, using ImageJ. EGL thickness was calculated by dividing the area of the EGL by the length of the EGL in midline sections. IGL density was calculated by counting the number of nuclei in three 40x fields from lobule eight in three midline sections and by dividing the number by the area of the region counted.

In order to reduce variation and address the fate of iPCs, we used P1-30 inbred mice (C57BL/6J) and analyzed half of the vermis. Analysis of the number of iPCs and PCs was performed on every other section from 14 μm-thick sections to avoid counting the same cells twice due to their larger soma size. On average 25--28 sections were counted per brain.

Intensity measurements for P27 and KI67 expression in iPCs compared to CALB1+ PCs at P1 were performed using ImageJ. iPC or PC nuclei were defined as the region of interest and the marker fluorescence intensity and the nuclear area were measured and reported as corrected total cell fluorescence (CTCF)/nuclear area. (CTCF = Integrated Density -- (Nuclear area X mean fluorescence of background readings).

PC soma size and dendrite length were calculated using randomly distributed TdT+ PCs from three midline sections (\>20 cells/section). Soma area was calculated by outlining the perimeter of the outer edges of each cell. Cells that showed primary dendrites were used for this analysis to ensure that the region where the maximum soma area observed was used for the analyses. For dendrite length quantifications, primary and secondary dendrite length was measured and summed and PCs around the base of fissures were omitted.

Behavioral testing {#s3-6}
------------------

5 week old animals (No DT: n = 17, DT\@P1: n = 9 and DT\@P5: n = 11) were used to assess differences in motor behavior. The same sets of mice were used for all three tests described below.

### Rotarod {#s3-6-1}

An accelerating rotarod (47650; Ugo Basile) was used for these experiments. Animals were put on the rod, and allowed to run till the speed reached to 5 rpm. Then the rod was accelerated from 5 to 40 rpm over the course of 300 s. Recording was stopped at 305 s. Time of fall was recorded for each animal. Analysis was performed three times a day on three consecutive days. Between each trial, animals were allowed to rest for 10 min in their home cage.

### Grip strength {#s3-6-2}

To test whether any effects observed in the rotarod test were due to muscle weakness, grip strength measurements were performed using a force gauge (1027SM Grip Strength Meter with Single Sensor, Columbus Instruments). Animals were allowed to hold a horizontal grip while being gently pulled away by holding the base of their tail. Measurements were performed 5 times with 5 min resting periods in between. Force amount was recorded. Data was normalized to mouse's weight and represented in (Force/gram).

### Footprinting analysis {#s3-6-3}

Forefeet and hindfeet were painted with red and blue nontoxic acrylic paint (Crayola), respectively. Animals were allowed to walk on a strip of paper laid along the floor of a 50 cm long, 10 cm wide custom-made Plexiglas tunnel with a dark box at the far end. Three runs/mouse were performed and the distances between the markings were measured.

Statistical analysis {#s3-7}
--------------------

Prism (GraphPad) was used for all statistical analysis. Statistical comparisons used in this study were Student's two-tailed t-test; One-way and Two-way analysis of variance (ANOVA), followed by post hoc analysis with Tukey's test for multiple comparisons. Relevant F-statistics and p values are stated in the figure legends and the p values of the relevant post hoc multiple comparisons are shown in the figures. Summary of all the statistical analysis performed can be found in [Figure 1---source data 2](#fig1sdata2){ref-type="supplementary-material"}. The statistical significance cutoff was set at p\<0.05. Population statistics were represented as mean ± standard deviation (SD) of the mean. No statistical methods were used to predetermine the sample size, but our sample sizes are similar to those generally employed in the field. n ≥ 3 mice were used for each experiment and the numbers for each experiment are stated in the figure legends.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Age-dependent dormant resident progenitors are stimulated by injury to regenerate Purkinje neurons\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Liqun Luo as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by a Senior Editor.

As you can see from the reviews, while finding the manuscript of potential interest, all three reviewers have reservations about the major conclusion. Should you be able to address these critiques with new experiments, we would be happy to consider a new manuscript in the future.

*Reviewer \#1:*

Following their recent fascinating discovery on developmental plasticity of neurogenesis of cerebellar granule cells (Wojcinski et al., 2017), Joyner and colleagues here examine the developmental plasticity of cerebellar Purkinje cells (PCs). After application of diphtheria toxin (DT) to mice that express DTR using Pcp2-Cre at P1 (which is expressed in about half of the PCs at that time), they found that these DTR-expressing PCs were indeed killed by \~P5. However, PC number recovered nevertheless. They ascribe this recovery to the proliferation of a latent progenitor they termed FEPs because they express the early PC marker FOXP2 but not the mature PC marker Calbidin. They found that FEPs were present throughout the P1 cerebellum at substantial number, but diminished in number at P5. Accordingly, ablating Pcp2-Cre+ PCs at P1 resulted in a much less significant recovery of PC numbers; the residual PCs nevertheless increased in soma size and dendritic length. Mice with P1 but not P5 PC ablation recovered normal motor function by a few standard assays.

Overall the paper is of high technical quality and findings are interesting. However, I have one major reservation in their interpretation that the proliferating cells that produce PCs represent \"a previously unidentified and normally dormant progenitor population.\" This proposal raises a number of questions: What is the normal function of these FEPs (they surely cannot just prepare for DT/DTR-induced cell killing)? What is their fate if no injury occurs? If we do not know their normal fate, how can we claim that they are \"unipotent\"? One alternative (and simpler) interpretation is that these FEPs are immature PCs that somehow can go back to cell cycle if their neighboring PCs are lost, and this ability diminishes as development proceeds (from P1 to P5). Indeed there is precedent in other neuronal types, such as horizontal cells in the retina, which can undergo cell division after fully differentiated in adults after loss of certain cell cycle inhibitor/tumor suppressor genes (Ajioka et al., 2007). It is possible that transient down-regulation of these cell cycle inhibitors in immature PCs, triggered by environmental signals due to loss of neighboring PCs, could cause immature PCs to re-enter the cell cycle. To me, this alternative developmental plasticity is no less interesting.

I have a few other technical critiques:

1\) It seems unusual that there are fewer tdT+ neurons in the Pcp2-Cre;Ai14;LSLDTR mouse following DT injection (see Figure 1J-M and compare Figure 1P and 1Q). Is Pcp2-Cre, which should be expressed in all normal PCs after P7, no longer active in these \"new\" PC replacement cells? If so, how do we know these are real and/or functioning PCs?

2\) In the P5 killing experiment, presumably by then Pcp2-Cre is expressed in a larger fraction of PCs compared with P1 (it would be useful to quantify this as done in P1 mice). Can this contribute to the difference between P1 and P5 ablation?

3\) It appears that the authors deduce PC soma size from 14 µm sections. Given PC soma size is larger than 14 µm, this kind of analysis would produce a large number of half-cut, incomplete PC somal images, which might skew the conclusion?

*Reviewer \#2:*

This manuscript describes regeneration of cerebellar Purkinje cells following diphtheria toxin injection at P1 but not at P5 and suggests that this regeneration is through cell division of a \"previously unidentified progenitor population\". Based on the data shown and previous studies of PC cell number, other possibilities exist to explain the findings. I am not convinced that the paper demonstrates generation of new Purkinje cells.

The specific comments are:

1\) There is wide variability in the number of cells expressing Td-tomato/diphtheria toxin receptor at P1 (+/- 22%) which makes it difficult to know how many cells are dying. No counts of the number of cells expressing Td-tomato/diphtheria toxin are given for P5 mice. Presumably the percent of cells would be higher as Pcp2 is not fully expressed in all PCs at P1.

2\) The representative image of DT treated PCs at P30 (Figure 1M) clearly shows a large number of missing PCs which would normally form a continuous monolayer, suggesting that the number of PCs did not recover from cell death. Is this a representative image?

3\) Throughout the figures, co-labeling of PC markers with proliferation markers is not convincing. Images showing definitive co-localization should be provided.

4\) In general, the quality of the images is not high and very few co-labeled cells are shown. It is not clear that some of the very few BrdU^+^ cells shown are not Bergmann glial cells. High quality images of BLBP stained BGs would be more convincing than the low power images provided. In general, higher magnification and resolution images would be potentially more convincing than the data shown.

5\) Other studies have shown BrdU labeling of PCs in the adult, suggesting that BrdU or Thy incorporation assays detect DNA replication as well as cell division. Again, the co-labeling experiments with Ki67 and BrdU are not convincing. H3 would have been stronger evidence for cell division.

6\) The authors suggest that Calb1+ PCs can develop within one day after a putative cell division. How do they imagine such cells would differentiate, i.e. extend dendrites into the field of parallel fibers? There are no images of the newly generated PCs that convince me that they are immature PCs.

7\) There is literature suggesting that PCs undergo programmed cell death. While no direct studies have shown this, Bcl overexpression mice and Bax knockout mice both have \~30% more PCs. The authors should discuss these findings and how it might affect their results. If an immature (CALB1-) pool of PCs persists until P5, this would provide an alternative view to the idea that new cells are generated from \"unidentified precursors\".

*Reviewer \#3:*

In this manuscript, Baylin et al. examined injury induced regeneration pf Purkinjie cells in neonates and proposed a model that upon elimination of Purkinje cells, a previously unknown quiescent progenitor population can be rapidly activated to replenish the loss cells (within 24hrs), resulting in normal cerebellum development. Furthermore, this progenitor population lost its capacity around P5. While the topic is interesting, the result is not convincing. High doses of BrdU is known to label DNA repair, especially in the context of massive injury and the authors mostly used protein markers for cell type identification. The process occurs so quickly (within 24 hrs) and in the fetal tissue. The authors should be able to use slice imaging to observe the death and birth of Purkinje cells directly, to illuminate any doubt of their model. In addition, the authors can use onco-retroviruses for lineage tracing to label new neurons and observe distinct Purkinje cell morphology.

\[Editors' note: what now follows is the decision letter after the authors resubmitted for further consideration.\]

Thank you for resubmitting your work entitled \"Age-dependent dormant resident progenitors are stimulated by injury to regenerate Purkinje neurons\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Sean Morrison as the Senior Editor and Mary Hatten as the Reviewing Editor.

You did a good job of addressing the key reviewer comments. The manuscript was particularly improved by the addition of data from confocal imaging of Ki67, pH3, and BrdU and retroviral labelling. You have provided clearer images of dividing immature Purkinje cells in response to diphtheria toxin ablation of \~50% of PCs. Inclusion of additional proliferation markers with confocal imaging show that FoxP2 cells can divide. Retroviral infection was also used to mark cells that had divided. These additional data provide enough evidence for publication, but we would ask you address a few additional details:

1\) We are concerned with the use of the term \"FoxP2 expressing progenitor (FEP)\" as all PCs express FoxP2, mature or not. The cells you are studying are more clearly defined by their low levels of CALB1. Please consider that issue with respect to terminology.

2\) Details are needed describing which retrovirus was used, the source, plasmid map, production etc. Some retroviruses do infect non-dividing cells so please include a discussion of why you believe your retrovirus only infects non-dividing cells.

3\) In Figure 3B, Calb1 and FoxP2 appear to be mislabeled.

4\) Figure 3---figure supplement 7 please provided separate images for each channel.

5\) It appears that FoxP2 is partially outside the nucleus in BrdU^+^ cells (likely why the co-labeling was not obvious in non-confocal images). Is this the case? If so it would be interesting to discuss.

10.7554/eLife.39879.034

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> As you can see from the reviews, while finding the manuscript of potential interest, all three reviewers have reservations about the major conclusion. Should you be able to address these critiques with new experiments, we would be happy to consider a new manuscript in the future.

The main concern of all the reviewers was that given how unusual our finding is that new Purkinje cells (PCs) can be generated after birth, we need to provide additional evidence for this finding. In addition, we should address whether FEPs are normally in the PC lineage. We have made the following major changes to our manuscript that we hope now convince the reviewers that new PCs are produced by proliferation of a transient progenitor in the PC lineage when neighbor PCs are killed:

1\) We have performed GFP-retroviral labeling of proliferating FEPs following injury and show they become PCs. These results are presented in the revised Figure 2D-I.

2\) As an approach to study the fate of FEPs during normal development, we quantified the number of FEPs and PCs from inbred newborn mice at postnatal day (P) 1, 5 and 30. We find that the number of PCs at P30 is similar to the number of PCs plus FEPs at P1, indicating that FEPs normally have a delay in differentiation until after birth. This result is incorporated into the revised Figure 3C and discussion of results.

3\) We included confocal images of co-localization of EdU+ FEPs with additional proliferation markers, Ki67 and pH3 (Figure 3E-X).

4\) We show that BrdU incorporation into PCs is not due to DNA damage following ablation by diphtheria toxin (Figure 2---figure supplement 3).

5\) Throughout the paper, we improved the quality of our images and added orthogonal projections to show co-localization.

6\) We have expanded our Discussion to include the reviewers' suggestions about other possible regenerative mechanisms and the fate of FEPs.

Reviewer \#1:

> \[...\] Overall the paper is of high technical quality and findings are interesting. However, I have one major reservation in their interpretation that the proliferating cells that produce PCs represent \"a previously unidentified and normally dormant progenitor population.\" This proposal raises a number of questions: What is the normal function of these FEPs (they surely cannot just prepare for DT/DTR-induced cell killing)? What is their fate if no injury occurs? If we do not know their normal fate, how can we claim that they are \"unipotent\"?

We agree with the reviewer that these are important questions, and have now addressed them by performing additional experiments to study the normal fate of FEPs. We reasoned that if FEPs are normally destined to become PCs but are delayed in their differentiation (expression of CALB1) until after birth, then the number of CALB1+ cells at P30 should be similar to the number of CALB1+ cells plus FEPs at P1. However, our original data was unable to address this question due to the high variation we observed between animals because: 1) Our ablation experiments were performed in mice with an outbred background, and 2) quantifications were performed on only 3 midline sections/brain. The variation at P30 was \~12.5% of the mean, which is higher than the total number of FEPs present at P1 (\~10% of PCs) making it statistically impossible to address the fate of FEPs. To overcome this barrier, we analyzed the number of FEPs and CALB1+ PCs on every other slide of a half vermis (\~25-28 sections) in inbred C57Bl/6 mice at P1, P5 and P30 (Figure 3C). Indeed, with this approach, the variation was only \~5% of the mean at P30. New data presented in Figure 3C shows a significant increase in the number of CALB1+ cells at P30 compared to P1 and the total number of FEPs plus PCs at P1 was not statistically different than the number of PCs at P30. This result is consistent with the reviewer's suggestion below that FEPs normally differentiate into PCs after birth.

> One alternative (and simpler) interpretation is that these FEPs are immature PCs that somehow can go back to cell cycle if their neighboring PCs are lost, and this ability diminishes as development proceeds (from P1 to P5). Indeed there is precedent in other neuronal types, such as horizontal cells in the retina, which can undergo cell division after fully differentiated in adults after loss of certain cell cycle inhibitor/tumor suppressor genes (Ajioka et al., 2007). It is possible that transient down-regulation of these cell cycle inhibitors in immature PCs, triggered by environmental signals due to loss of neighboring PCs, could cause immature PCs to re-enter the cell cycle. To me, this alternative developmental plasticity is no less interesting.

We fully agree with the reviewer's hypothesis, and indeed our new data described above supports the idea. We have also performed immunofluorescent analysis on sections at P1 for KI67 and P27^kip1^, followed by quantification of fluorescent intensity of either marker in the nucleus of FEPs compared to CALB+ PCs. This data is represented in new Figure 3---figure supplement 7. Although both populations showed overall weaker staining for both markers compared to granule cell precursors, we observed that FEPs had significantly lower P27 levels and higher Ki67 levels compared to PCs at P1. We have removed statements regarding the unipotency of FEPs from our manuscript, since we do not have the tools (FoxP2-FlpoER mice) for inducible fate mapping. We have added a discussion of possible alternative developmental plasticity phenomena to our revised paper.

> I have a few other technical critiques:
>
> 1\) It seems unusual that there are fewer tdT+ neurons in the Pcp2-Cre;Ai14;LSLDTR mouse following DT injection (see Figure 1J-M and compare Figure 1P and 1Q). Is Pcp2-Cre, which should be expressed in all normal PCs after P7, no longer active in these \"new\" PC replacement cells? If so, how do we know these are real and/or functioning PCs?

Thank you for pointing this out. All the reviewers had a similar expectation. In our hands, however, the recombination efficiency of Pcp2-Cre is highly variable and lower than previously reported. We have analyzed litters from different males, but were unable to achieve higher recombination.

We added a more extensive analysis of the recombination efficiency at P1, P5 and P30 to our revised manuscript. This analysis shows no increase in the recombination efficiency after P1 (Figure 1---figure supplement 1F). We also show that following ablation at P1, all of the TdT-expressing cells are cleared and replaced within a week after injury, and that of the \~50% newly regenerated PCs, \~50% turn on TdT+ with time. This percentage is similar to the 50% of cells that normally express TdT and therefore results in a reduction in the total number TdT+ cells at P30 in P1-*PC-DTR* mice, compared to controls. We have included this explanation in the new manuscript.

As for normal function, the lack of motor behavior phenotype in P1-*PC-DTR* mice provides functional evidence that the regenerated PCs integrate properly into the CB circuit. Furthermore, in order to study the morphology of the regenerated PCs in adult mice, we performed BrdU injections 10-12 hr after DT and analyzed them at P30 (Figure 2---figure supplement 2). We observed that the cell bodies and dendritic trees of BrdU^+^ PCs at P30 appear normal.

> 2\) In the P5 killing experiment, presumably by then Pcp2-Cre is expressed in a larger fraction of PCs compared with P1 (it would be useful to quantify this as done in P1 mice). Can this contribute to the difference between P1 and P5 ablation?

As described above, we did not observe a significant increase in the recombination efficiency of Pcp2-Cre at P5 compared to P1. The numbers of TdT+ cells/section (hence the number of cells ablated) were similar at the two ages. Therefore, we do not think that this is a contributing factor to the phenotype observed in P5-*PC-DTR* mice. We have highlighted these results in the text in the relevant sections and also added a new graph to Figure 1---figure supplement 1F that shows the similar recombination efficiency at the two ages.

> 3\) It appears that the authors deduce PC soma size from 14 µm sections. Given PC soma size is larger than 14 µm, this kind of analysis would produce a large number of half-cut, incomplete PC somal images, which might skew the conclusion?

We thank the reviewer for pointing out this detail that we did not fully describe. For our soma size analysis, we only quantified the cells that had a visible primary dendrite, as this should indicate that the section was taken from the largest region of the PC soma. However, in order to ensure we are not including any bias to our quantifications, we repeated the same quantification with sections that were either 14 µm or 35 µm thick from the same brain and compared the results. As can be seen in the graph below, we found the soma sizes were similar using both methods (**Figure 1**, t-test, P=0.13). Therefore, we are confident in our results and we did not replace the quantifications provided in the first version of the paper. We also revised the Methods section for paper to clearly describe our approach.

![Soma size determination by quantifying thick and thin histological sections gave similar results.](elife-39879-resp-fig1){#respfig1}

Reviewer \#2:

> This manuscript describes regeneration of cerebellar Purkinje cells following diphtheria toxin injection at P1 but not at P5 and suggests that this regeneration is through cell division of a \"previously unidentified progenitor population\". Based on the data shown and previous studies of PC cell number, other possibilities exist to explain the findings. I am not convinced that the paper demonstrates generation of new Purkinje cells.
>
> The specific comments are:
>
> 1\) There is wide variability in the number of cells expressing Td-tomato/diphtheria toxin receptor at P1 (+/- 22%) which makes it difficult to know how many cells are dying. No counts of the number of cells expressing Td-tomato/diphtheria toxin are given for P5 mice. Presumably the percent of cells would be higher as Pcp2 is not fully expressed in all PCs at P1.

As described in detail above (reviewer \# 1, answer 3), we have now included the P5 data and described that in our hands we do not observe an increase in the recombination efficiency (and number of TdT+ cell) at P1 compared to P5 (or P30)(revised Figure 1---figure supplement 1). Although the variation in our recombination efficiency was high, we were able to observe regeneration of PCs since all of the P30 P1-*PC-DTR* animals had a normal number of PCs, showing that whatever number of PCs was lost (30-70% of PCs) they were replaced. There was likely an effect of high recombination variation in P5-*PC-DTR* animals because the behavior analysis showed that not every P5-*PC-DTR* animal was abnormal. When we analyzed the correlation between latency to fall from the rod and number of PCs, we observed that animals with smallest numbers of PCs performed the worse.

> 2\) The representative image of DT treated PCs at P30 (Figure 1M) clearly shows a large number of missing PCs which would normally form a continuous monolayer, suggesting that the number of PCs did not recover from cell death. Is this a representative image?

We apologize for the confusion. We have replaced the picture with a more representative one. Due to our section thickness (14µm) we consistently see holes in the PCL in controls and mutant mice, depending on where in the PC soma the section is cut. Because of this, we performed all our analyses on 3 midline sections/brain.

> 3\) Throughout the figures, co-labeling of PC markers with proliferation markers is not convincing. Images showing definitive co-localization should be provided.
>
> 4\) In general, the quality of the images is not high and very few co-labeled cells are shown. It is not clear that some of the very few BrdU^+^ cells shown are not Bergmann glial cells. High quality images of BLBP stained BGs would be more convincing than the low power images provided. In general, higher magnification and resolution images would be potentially more convincing than the data shown.
>
> 5\) Other studies have shown BrdU labeling of PCs in the adult, suggesting that BrdU or Thy incorporation assays detect DNA replication as well as cell division. Again, the co-labeling experiments with Ki67 and BrdU are not convincing. H3 would have been stronger evidence for cell division.

In order to address these three similar points (3-5), we have added orthogonal projections from zstacks obtained by confocal microscopy to demonstrate better co-localization in our figures, in addition to showing examples of Ki67+ and phosho-H3+, EdU+ FEPs. Furthermore, as requested by reviewer \#3, we have performed retroviral labeling of proliferating FEPs following ablation, further confirming that the PCs are replaced by a progenitor that proliferates (new Figures 2 and 3 and the related supplementary figures).

In addition to this newly presented evidence, an increase in the number of FEPs following DT at P1 further confirms that the regeneration is achieved by a proliferating progenitor (Figure 3D).

> 6\) The authors suggest that Calb1+ PCs can develop within one day after a putative cell division. How do they imagine such cells would differentiate, i.e. extend dendrites into the field of parallel fibers? There are no images of the newly generated PCs that convince me that they are immature PCs.

We were also surprised that regeneration is so rapid, but as we now discuss in the paper, we think that the reason PCs are regenerated at P1 and not at P5 is in part because by P5 the circuit is too mature for the new PCs to integrate. At P1, there is little molecular layer (where the PC dendrites synapse with the parallel fibers of granule cells). In addition, at P1-2 PCs have not settled into a monolayer, and have not formed their unipolar dendrites (they are multi-polar). The PCs settle into a monolayer and become unipolar and form distinct dendrites around P3-P5.

Because CALB1+ PCs are immature at P1-P2, we were not able to distinguish whether FEPs have a more immature phenotype than PCs. As described above (response \#1 to reviewer 1), we followed the PCs that incorporated BrdU after injury to P30, and found they develop normal dendritic trees, and our behavior study provides functional evidence that the regenerated PCs successfully integrate into the circuitry (Figure 2---figure supplement 2).

Finally, our new data represented in Figure 3C suggests that FEPs normally differentiate into CALB1+ PCs during the first week after birth, which shows that the CB circuitry is able to accommodate maturation of PCs soon after birth. We now discussed the implications of these results in our manuscript.

> 7\) There is literature suggesting that PCs undergo programmed cell death. While no direct studies have shown this, Bcl overexpression mice and Bax knockout mice both have \~30% more PCs. The authors should discuss these findings and how it might affect their results. If an immature (CALB1-) pool of PCs persists until P5, this would provide an alternative view to the idea that new cells are generated from \"unidentified precursors\".

Although we were not able to observe clear cell death of PCs by TUNEL at P3 and P5 in wild type mice, our new data indicates there might be a small drop in the total number of cells (FEPs + PCs) at P5, compared to P1 (Figure 3C). Our unpublished results, combined with previous literature suggests that there are multiple mechanism to ensure the correct number of PCs are generated in newborn mice, including apoptosis in the embryo to scale PC numbers with respect to other components of the CB circuitry and FEPs which replace any PCs lost to injury around birth. As described in our responses to reviewer 1, we agree that the FEPs are likely immature PCs that delay their differentiation until after birth, and this is now discussed in the paper.

Reviewer \#3:

> In this manuscript, Baylin et al. examined injury induced regeneration pf Purkinjie cells in neonates and proposed a model that upon elimination of Purkinje cells, a previously unknown quiescent progenitor population can be rapidly activated to replenish the loss cells (within 24hrs), resulting in normal cerebellum development. Furthermore, this progenitor population lost its capacity around P5. While the topic is interesting, the result is not convincing. High doses of BrdU is known to label DNA repair, especially in the context of massive injury and the authors mostly used protein markers for cell type identification. The process occurs so quickly (within 24 hrs) and in the fetal tissue. The authors should be able to use slice imaging to observe the death and birth of Purkinje cells directly, to illuminate any doubt of their model. In addition, the authors can use onco-retroviruses for lineage tracing to label new neurons and observe distinct Purkinje cell morphology.

We thank the reviewer for the excellent suggested experiments to remove any doubt of our conclusions. We performed intracranial injections of a GFP-expressing retrovirus 12 hours after DT injection at P1 to P1-*PC-DTR* animals and controls. When we analyzed animals 3 weeks after retroviral infection, we indeed observed rare GFP-labeled PCs, and only in the P1-*PC-DTR* animals. In No DT controls only the expected granule cells and glial cells were labeled. These results thus show that following depletion, ablated PCs are replenished by a proliferating progenitor (Figure 2D-I). In order to determine whether the BrdU incorporation we observed is due to DNA repair induced by DT-mediated cell death or actually due to proliferation, we performed irradiation (IR) of pups and repeated the BrdU regimen we used for our experiments. These new results are presented in the new Figure 2---figure supplement 3. We observed that following 3 injections of BrdU after IR, many cells showed y-H2AX foci in their nucleus, including FOXP2+ cells, however, we could not detect BrdU incorporation in any of the cells. On the other hand, high levels of BrdU incorporation were observed in the FOXP2+ cells in P1-*PC-DTR* animals of the same cohort. No DT control animals showed no BrdU incorporation in FOXP2+ cells, consistent with our previous observation. Furthermore, the lack of BrdU incorporation in the ectopic TdT+ cells (Figure 2---figure supplement 1) and the increase in the number of FEPs (Figure 3D) 12 hours after DT injection also support our conclusion that BrdU incorporation is due to proliferation and not DNA repair.

We have also tried performing live imaging of P1.5 CB slices from P1-*PC-DTR* animals on a *FoxP2TdT* background, with and without PC ablation (DT in vivo). One of the problems we have encountered is that the dense packing of the PCs at P1.5 makes it impossible to observe single PC cell bodies with the cytoplasmic TdT in our system. Due to the inconclusive initial results we obtained, we have not included the slice-culturing experiments in the new paper.

\[Editors\' note: the author responses to the re-review follow.\]

> You did a good job of addressing the key reviewer comments. The manuscript was particularly improved by the addition of data from confocal imaging of Ki67, pH3, and BrdU and retroviral labelling. You have provided clearer images of dividing immature Purkinje cells in response to diphtheria toxin ablation of \~50% of PCs. Inclusion of additional proliferation markers with confocal imaging show that FoxP2 cells can divide. Retroviral infection was also used to mark cells that had divided. These additional data provide enough evidence for publication, but we would ask you address a few additional details:
>
> 1\) We are concerned with the use of the term \"FoxP2 expressing progenitor (FEP)\" as all PCs express FoxP2, mature or not. The cells you are studying are more clearly defined by their low levels of CALB1. Please consider that issue with respect to terminology.

We have changed the terminology used in our manuscript. In the modified version, we are referring to the CALB1-/low FOXP2-expressing PC progenitors as immature PCs or iPCs.

> 2\) Details are needed describing which retrovirus was used, the source, plasmid map, production etc. Some retroviruses do infect non-dividing cells so please include a discussion of why you believe your retrovirus only infects non-dividing cells.

We have updated our manuscript with the relevant details about the retrovirus used. As noted in the acknowledgement in the paper, we obtained it as a gift from our colleague Songhai Shi. We have included a paper describing his use of the retrovirus: Yu et al., 2009 and a review by Connie Cepko of the use of retroviruses for labeling neural progenitors, as well as references to the origin of the retrovirus vector. The retrovirus is a replication-incompetent retrovirus (Moloney murine leukemia virus) that expresses a modified version of GFP (superfolding GFP instead of EGFP) that was produced in HEK293T cells using the pCMV-vsvg and pCMV-gp packaging plasmids. Dr. Shi's lab, as well as others in the field of neurogenesis, have been using the retrovirus for their clonal analysis of proliferating neural progenitors in the mouse neocortex for years. Such studies require that the virus only infects dividing cells. This is also a known property of retroviruses, since they require breakdown of the nuclear envelope during mitosis for transduction. One additional note is that we only observed labeled PCs in mice that received diphtheria toxin injection at P1 and never in the controls.

> 3\) In Figure 3B, Calb1 and FoxP2 appear to be mislabeled.

We apologize for the mistake. We corrected the labels.

> 4\) Figure 3---figure supplement 7 please provided separate images for each channel.

We added the single channel images to Figure 3---figure supplement 7.

> 5\) It appears that FoxP2 is partially outside the nucleus in BrdU^+^ cells (likely why the co-labeling was not obvious in non-confocal images). Is this the case? If so it would be interesting to discuss.

Thank you for noticing this interesting point. It was a consistent finding that FOXP2 and BrdU (also pH3) signals do not overlap well in the PC nucleus. However, both signals appear to be in the nucleus. We highlighted this observation in the main text (and Figure 3---figure supplement 6 for pH3). We think that the poorly understood nature of the large PC nuclei where the DNA may only be condensed enough in particular areas of the nucleus (perhaps heterochromatin) for the BrdU to be detected may play a role in this phenomenon in non-dividing PCs, and in dividing PCs FOXP2 protein likely undergoes dynamics changes in chromatin localization.

[^1]: John Wayne Cancer Institute, Santa Monica, United States.

[^2]: Center for Interdisciplinary Research in Biology, College de France, Paris, France.
